Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents
- Status
- COMPLETED
- Phase
- PHASE3
A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE3
Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
- Status
- COMPLETED
- Phase
- PHASE3
Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Immune Profile in Subjects With New Onset Type 1 Diabetes
- Status
- COMPLETED
- Phase
- NA
Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients
- Status
- COMPLETED
- Phase
- PHASE4
Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy
- Status
- COMPLETED
- Phase
- PHASE4
Single and Repeated Dose Escalation Study of GSK2838232
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma
- Status
- WITHDRAWN
- Phase
- PHASE2